Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 4
2016 3
2017 5
2018 3
2019 4
2020 1
2021 5
2022 9
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD.
Coufal S, Kverka M, Kreisinger J, Thon T, Rob F, Kolar M, Reiss Z, Schierova D, Kostovcikova K, Roubalova R, Bajer L, Jackova Z, Mihula M, Drastich P, Tresnak Hercogova J, Novakova M, Vasatko M, Lukas M, Tlaskalova-Hogenova H, Jiraskova Zakostelska Z. Coufal S, et al. Among authors: rob f. J Immunol Res. 2023 Jun 20;2023:1535484. doi: 10.1155/2023/1535484. eCollection 2023. J Immunol Res. 2023. PMID: 37383609 Free PMC article.
Single-dose cefixime 800 mg plus doxycycline 100 mg twice a day for 7 days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a randomised clinical trial.
Bížová B, Procházka P, Nyčová E, Bořil P, Kubele J, Poláková A, Zemanová Z, Unemo M, Rob F. Bížová B, et al. Among authors: rob f. Clin Microbiol Infect. 2024 Feb;30(2):211-215. doi: 10.1016/j.cmi.2023.11.006. Epub 2023 Nov 18. Clin Microbiol Infect. 2024. PMID: 37981059 Clinical Trial.
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.
Reiss Z, Rob F, Kolar M, Schierova D, Kreisinger J, Jackova Z, Roubalova R, Coufal S, Mihula M, Thon T, Bajer L, Novakova M, Vasatko M, Kostovcikova K, Galanova N, Lukas M, Kverka M, Tresnak Hercogova J, Tlaskalova-Hogenova H, Jiraskova Zakostelska Z. Reiss Z, et al. Among authors: rob f. Front Cell Infect Microbiol. 2023 Jan 10;12:1064537. doi: 10.3389/fcimb.2022.1064537. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36704107 Free PMC article.
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study.
Rob F, Schierova D, Stehlikova Z, Kreisinger J, Roubalova R, Coufal S, Mihula M, Jackova Z, Kverka M, Thon T, Kostovcikova K, Bajer L, Drastich P, Hercogova JT, Novakova M, Kolar M, Vasatko M, Lukas M, Tlaskalova-Hogenova H, Jiraskova Zakostelska Z. Rob F, et al. PLoS One. 2022 Dec 30;17(12):e0277576. doi: 10.1371/journal.pone.0277576. eCollection 2022. PLoS One. 2022. PMID: 36584073 Free PMC article.
Ongoing evolution of Chlamydia trachomatis lymphogranuloma venereum: exploring the genomic diversity of circulating strains.
Seth-Smith HMB, Bénard A, Bruisten SM, Versteeg B, Herrmann B, Kok J, Carter I, Peuchant O, Bébéar C, Lewis DA, Puerta T, Keše D, Balla E, Zákoucká H, Rob F, Morré SA, de Barbeyrac B, Galán JC, de Vries HJC, Thomson NR, Goldenberger D, Egli A. Seth-Smith HMB, et al. Among authors: rob f. Microb Genom. 2021 Jun;7(6):000599. doi: 10.1099/mgen.0.000599. Microb Genom. 2021. PMID: 34184981 Free PMC article.
34 results